KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Change in Cash (2016 - 2025)

Historic Change in Cash for Medpace Holdings (MEDP) over the last 11 years, with Q4 2025 value amounting to $211.7 million.

  • Medpace Holdings' Change in Cash rose 158872.05% to $211.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$172.4 million, marking a year-over-year decrease of 14065.86%. This contributed to the annual value of -$172.4 million for FY2025, which is 14065.86% down from last year.
  • Medpace Holdings' Change in Cash amounted to $211.7 million in Q4 2025, which was up 158872.05% from $239.0 million recorded in Q3 2025.
  • Medpace Holdings' Change in Cash's 5-year high stood at $239.0 million during Q3 2025, with a 5-year trough of -$395.1 million in Q2 2025.
  • Moreover, its 5-year median value for Change in Cash was $36.9 million (2021), whereas its average is $11.0 million.
  • As far as peak fluctuations go, Medpace Holdings' Change in Cash tumbled by 78672.5% in 2022, and later skyrocketed by 557928.52% in 2023.
  • Over the past 5 years, Medpace Holdings' Change in Cash (Quarter) stood at $62.9 million in 2021, then crashed by 104.36% to -$2.7 million in 2022, then surged by 5579.29% to $150.2 million in 2023, then tumbled by 91.66% to $12.5 million in 2024, then skyrocketed by 1588.72% to $211.7 million in 2025.
  • Its Change in Cash was $211.7 million in Q4 2025, compared to $239.0 million in Q3 2025 and -$395.1 million in Q2 2025.